NYSE: OGN - Organon & Co.

Yield per half year: -30.74%
Dividend yield: +6.42%
Sector: Healthcare

Company Analysis Organon & Co.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (16.13 $) is less than fair price (17.64 $)
  • Dividends (6.42%) are higher than the sector average (1.3%).
  • The stock's return over the last year (-13.18%) is higher than the sector average (-16.29%).

Disadvantages

  • Current debt level 72.65% has increased over 5 years from 0.986%.
  • The company's current efficiency (ROE=-1461.43%) is lower than the sector average (ROE=-82.41%)

Similar companies

PFIZER

PerkinElmer

Humana

AbbVie

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Organon & Co. Healthcare Index
7 days -1.3% -14% -2.8%
90 days -3.1% -17% -2.9%
1 year -13.2% -16.3% 15.5%

OGN vs Sector: Organon & Co. has outperformed the "Healthcare" sector by 3.11% over the past year.

OGN vs Market: Organon & Co. has significantly underperformed the market by -28.66% over the past year.

Stable price: OGN is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: OGN with weekly volatility of -0.2535% over the past year.

3. Summary of the report

3.1. General

P/E: 3.54
P/S: 0.5782

3.2. Revenue

EPS 3.99
ROE -1461.43%
ROA 8.48%
ROIC 13.88%
Ebitda margin 24.8%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (16.13 $) is lower than the fair price (17.64 $).

Price not significantly lower than the fair price: The current price (16.13 $) is slightly lower than the fair price by 9.4%.

4.2. P/E

P/E vs Sector: The company's P/E (3.54) is lower than that of the sector as a whole (114.26).

P/E vs Market: The company's P/E (3.54) is lower than that of the market as a whole (73.51).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (-51.73) is lower than that of the sector as a whole (9.02).

P/BV vs Market: The company's P/BV (-51.73) is lower than that of the market as a whole (22.32).

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.5782) is lower than that of the sector as a whole (4.1).

P/S vs Market: The company's P/S indicator (0.5782) is lower than that of the market as a whole (15.92).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (7.53) is lower than that of the sector as a whole (17.72).

EV/Ebitda vs Market: The company's EV/Ebitda (7.53) is lower than that of the market as a whole (22.62).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -10.53% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-10.53%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).

5.4. ROE

ROE vs Sector: The company's ROE (-1461.43%) is lower than that of the sector as a whole (-82.41%).

ROE vs Market: The company's ROE (-1461.43%) is lower than that of the market as a whole (25.01%).

5.5. ROA

ROA vs Sector: The company's ROA (8.48%) is higher than that of the sector as a whole (6.75%).

ROA vs Market: The company's ROA (8.48%) is higher than that of the market as a whole (6.62%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (13.88%) is lower than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (13.88%) is higher than that of the market as a whole (9.31%).

6. Finance

6.1. Assets and debt

Debt Level: (72.65%) is a bit high in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0.986% to 72.65%.

Excess of debt: The debt is not covered by net income, percentage 856.3%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 6.42% is higher than the average for the sector '1.3%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 6.42% has been steadily paid over the past 7 years, DSI=1.

Weak dividend growth: The company's dividend yield 6.42% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (28.74%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
04.05.2024 Stahler Rachel A
Chief Information Officer
Purchase 20.4 62 200 3 049
04.05.2024 WALSH MATTHEW M
Chief Financial Officer
Purchase 20.4 169 524 8 310

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Organon & Co.

9.3. Comments